The Helios Heart Registry: A Standardized Registry for Patients With Specific Cardiac Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHelios Health Institute GmbH
About this trial
Investigator-initiated, prospective, non-randomized, open label, non-interventional multicenter registry to evaluate current treatment of three major cardiovascular disease entities in clinical practice using a standardized variable-set of relevant covariates and outcome measures.
Eligibility criteria
Qualifiers
Age of 18 years or older
Inpatient Treatment
Present diagnosis of at least one of the three cardiovascular disease entities of interest according to the current guidelines of the European Society of Cardiology (ESC): HF, CAD, AF
Disqualifiers
Inability to provide informed consent
Initial presentation (index hospitalization) in cardiogenic shock or other kinds of shock
Patient after heart transplantation or patient with present ventricular assist device (VAD)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
24,000 Participants
are grouped into 3 trial groupsSponsors and collaborators
Source ClinicalTrials.gov